文献速递癫痫认知障碍与痴呆

儿童发育性及癫痫性脑病与智力障碍合并癫痫的流行病学研究

Epidemiology of Developmental and Epileptic Encephalopathy and of Intellectual Disability and Epilepsy in Children.
PubMed 文献 · Neurology · 2022-12-29

该研究基于新西兰惠灵顿地区2000至2016年的脑电图记录,确定16岁以下儿童中发育性及癫痫性脑病(DEE)和智力障碍合并癫痫(ID+E)的人群累积发病率与患病率。DEE累积发病率为169/10万儿童(95%CI 144-199),ID+E为125/10万儿童(95%CI 95.4-165);33%的DEE和84%的ID+E患儿无法归入已知癫痫综合征。

要点

  • 16岁以下儿童中,癫痫合并发育障碍的时点患病率为175/10万儿童(95%CI 149-203)。
  • DEE累积发病率为169/10万儿童(95%CI 144-199),ID+E为125/10万儿童(95%CI 95.4-165)。
  • 33%的DEE和84%的ID+E患儿无法诊断为已知癫痫综合征。

核心结论

  • 16岁前癫痫合并发育障碍的发生率为1/340儿童,其中DEE为1/590,ID+E为1/800。
  • 27%的DEE和70%的ID+E患儿癫痫发作始于3岁以后,流行病学研究仅关注早发性DEE不能完全反映疾病负担。
  • 了解特定综合征与广泛DEE组的累积发病率对治疗试验规划至关重要;试验聚焦特定综合征,可能导致三分之一DEE患儿无法获得有效治疗。

研究设计与样本

  • 基于人群的研究,利用新西兰惠灵顿地区2000至2016年的脑电图记录确定16岁以下DEE或ID+E患儿。
  • 通过病历和脑电图复习诊断癫痫综合征,计算时点患病率和累积发病率。
  • 队列共纳入235例发育障碍合并癫痫患儿(58%为男性),其中DEE 152例(65%),ID+E 83例(35%)。
  • 癫痫发作中位起病年龄为15.4个月(范围第1天至15岁),中位随访时间为7.9年(范围0至18.2年)。

主要发现

  • 癫痫合并发育障碍的广泛组时点患病率为175/10万儿童(95%CI 149-203),其中DEE为112/10万,ID+E为63/10万。
  • DEE累积发病率为169/10万儿童(95%CI 144-199),ID+E为125/10万儿童(95%CI 95.4-165)。
  • 各癫痫综合征累积发病率(每10万儿童):婴儿癫痫性痉挛综合征58.2(95%CI 45.0-75.3),肌阵挛-失张力癫痫16.4(95%CI 9.69-27.7),Lennox-Gastaut综合征13.2(95%CI 4.1-41.9),Dravet综合征5.1(95%CI 2.1-12.2)。
  • DEE患儿中50/152(33%)无法诊断为已知癫痫综合征,ID+E患儿中70/83(84%)无法诊断。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: We aimed to determine the population-based cumulative incidence and prevalence of developmental and epileptic encephalopathies (DEEs) and intellectual disability and epilepsy (ID+E) in children. We analyzed the cumulative incidence of specific epilepsy syndromes. METHODS: Children younger than 16 years with a DEE or ID+E were ascertained using EEG records from 2000 to 2016 in the Wellington region of New Zealand. Epilepsy syndromes were diagnosed on medical record and EEG review. Point prevalence and cumulative incidence for children with epilepsy and developmental impairment, DEE and ID+E were calculated. Cumulative incidence for each epilepsy syndrome was calculated. RESULTS: The cohort comprised 235 children (58% male) with developmental impairment and epilepsy, including 152 (65%) with DEE and 83 (35%) with ID+E. The median age of seizure onset was 15.4 months (range day 1-15 years). The median follow-up from seizure onset was 7.9 years (range 0-18.2 years). Point prevalence for the broad group of children with epilepsy and developmental impairment was 175/100,000 children (95% CI 149-203; DEE 112 and ID+E 63/100,000 children). Cumulative incidence for DEE was 169/100,000 children (95% CI 144-199) and that for ID+E was 125/100,000 children (95% CI 95.4-165). Cumulative incidence per 100,000 children was as follows: infantile epileptic spasms syndrome 58.2 (95% CI 45.0-75.3), epilepsy with myoclonic-atonic seizures 16.4 (95% CI 9.69-27.7), Lennox-Gastaut syndrome 13.2 (95% CI 4.1-41.9), and Dravet syndrome 5.1 (95% CI 2.1-12.2). Fifty/152 (33%) of children with DEE and 70/83 (84%) with ID+E could not be diagnosed with a known epilepsy syndrome. DISCUSSION: Epilepsy and developmental impairment before the age of 16 years occurs in 1 in 340 children, with 1 in 590 having a DEE and 1 in 800 having ID+E. These individuals require significant health and community resources; therefore, these data will inform complex health service and education planning. Epidemiologic studies have focused on early childhood-onset DEEs. These do not fully reflect the burden of these disorders because 27% of DEEs and 70% of ID+E begin later, with seizure onset after the age of 3 years. Understanding the cumulative incidence of specific syndromes together with the broad group of DEEs is essential for the planning of therapeutic trials. Given trials focus on specific syndromes, there is a risk that effective therapies will not be developed for one-third of children with DEE.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Poke G, Stanley J, Scheffer IE, et al. Epidemiology of Developmental and Epileptic Encephalopathy and of Intellectual Disability and Epilepsy in Children. Neurology. 2022. PMID: 36581463. doi:10.1212/WNL.0000000000206758

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。